SCHEMBL4597652

SCHEMBL4597652

CCOc1cc(Cc2c[nH]c3ncccc23)cnc1-c1cc(C(F)(F)F)ccc1CN

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 4/20 0.49
KIT P10721 1/20 0.49
FGFR1 P11362 1/20 0.42
FGFR4 P22455 1/20 0.42
MET P08581 1/20 0.41
HTR2A P28223 2/20 0.41
HTR7 P34969 2/20 0.41
HTR6 P50406 2/20 0.41
GPR84 Q9NQS5 2/20 0.40
BRD4 O60885 1/20 0.36
CDC7 O00311 1/20 0.36
ROCK2 O75116 1/20 0.36
MAP4K4 O95819 1/20 0.36
PIM1 P11309 1/20 0.36
PRKACA P17612 1/20 0.36
CDK2 P24941 1/20 0.36
GSK3B P49841 1/20 0.36
HIPK2 Q9H2X6 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4560141 0.81 CSF1R (0.60) CSF1RKITFGFR1FGFR4MET
SCHEMBL4560772 0.75 GPR84 (0.47) CSF1RKITFGFR1FGFR4MET
SCHEMBL4560845 0.75 CYP3A4 (0.47) CSF1RKITFGFR1FGFR4MET
SCHEMBL1267123 0.70 CSF1R (0.62) CSF1RKITFGFR1FGFR4MET
SCHEMBL14147656 0.69 FGFR1 (0.64) CSF1RKITFGFR1FGFR4MET
SCHEMBL413742 0.69 CSF1R (0.56) CSF1RKITFGFR1FGFR4MET
SCHEMBL4605793 0.69 CYP3A4 (0.43) CSF1RKITHTR2ABRD4CDK2
SCHEMBL15279127 0.69 CSF1R (0.72) CSF1RKITFGFR1FGFR4MET
SCHEMBL1266304 0.68 CSF1R (0.62) CSF1RKITFGFR1FGFR4MET
SCHEMBL1267706 0.68 CSF1R (0.79) CSF1RKITFGFR1FGFR4MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008064265-A2 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR PLEXXIKON, INC. (US) 2008-05-29 WO disclosed